44,684views
00:00 / 00:00
de completadas
de completadas
de completadas
2024
2023
2022
2021
insulin and p. 331
insulin and p. 331
in insulinomas p. 357
insulin and p. 331, 333
in insulin deficiency p. 350
insulin and p. 333
insulin and p. 331
in insulin deficiency p. 350
anabolic effects of p. 331
deficiency in p. 350
diabetic ketoacidosis p. 355
for HHNS p. 355
fructose bisphosphatase-2 and p. 74
GIP effect on p. 378
glucagon and p. 333
glycogen regulation p. 71, 84
hypokalemia from p. 608
in pregnancy p. 331
production of p. 337
secretion of p. 333
signaling pathways for p. 351
somatostatin and p. 378
somatostatinomas and p. 355
insulin and C-peptide in p. 331
insulin deficiency p. 350
insulin and p. 333
in insulin deficiency p. 350
insulin deficiency/insensitivity p. 350
insulin deficiency/insensitivity p. 350
insulin in p. 331
insulin and p. 333
in insulin deficiency p. 350
insulin and p. 331
insulin and p. 331
insulin and p. 331
Insulin is a type of peptide hormone that reduces the amount of glucose in the blood. It is produced in the pancreas by beta cells. These cells are found within clusters of endocrine cells called the Islets of Langerhans, which are distributed across the pancreas. If the body is unable to produce enough insulin, then insulin therapy is used to keep the blood glucose low.
Insulin’s main function is to facilitate the transport of glucose from the blood into the various insulin-responsive tissues like muscle cells and adipose tissue. This hormone binds to insulin receptors on the surface of the cell membrane. Now, these receptors have two alpha and two beta subunits. Alpha subunits are located outside of the cell and they bind insulin; while two beta subunits are located within the cell and they have tyrosine kinase activity which carries signals into the cell. Once stimulated, insulin receptors cause intracellular storage vesicles, which contain glucose transport proteins called GLUT4, to fuse with the cell membrane. Next, the GLUT4 proteins embed themselves into the membrane and allow glucose to move into the cell.
As a result, insulin promotes glucose uptake and glycogenesis, which is the conversion of glucose to glycogen. Glycogenesis is the process that takes place in the liver and skeletal muscles. When glycogen storage capacity is reached, insulin promotes glycolysis, which is the breakdown of glucose to pyruvate. It also stimulates lipogenesis, the synthesis of fatty acids and triglycerides in the liver and adipose tissue; and amino acid uptake and protein synthesis in skeletal muscles.
Finally, insulin activates Na+/K+- ATPase pumps and shifts potassium into intracellular space, thereby decreasing potassium levels in the blood. On the flip side, insulin inhibits glycogenolysis, which stands for the breakdown of glycogen; and gluconeogenesis, which is glucose production from lactic acids and noncarbohydrate molecules. Finally, insulin inhibits lipolysis, the breakdown of lipids; and proteolysis, the breakdown of proteins.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.